Phlebopathies: from pathogenesis to treatment
Introduction. The prevalence of phlebopathies varies from 15 to 31%. The QoL of patients with phlebopathies is impaired. Phlebotropic therapy is the main method for treating phlebopathies. Aim. Evaluation of the efficacy and safety of micronized purified flavonoid fraction (MPFF) (Troxaktiv). Materi...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Russo |
| Argitaratua: |
Remedium Group LTD
2023-11-01
|
| Saila: | Амбулаторная хирургия |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.a-surgeon.ru/jour/article/view/386 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|